From the Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Crit Pathw Cardiol. 2023 Sep 1;22(3):91-94. doi: 10.1097/HPC.0000000000000324. Epub 2023 Jul 7.
Hypercholesterolemia (HCL) is common among emergency department (ED) and ED observation unit (EDOU) patients with chest pain but is not typically addressed in these settings. The objective of this study was to assess patient attitudes towards EDOU-based HCL care using the Health Belief Model.
We conducted a cross-sectional survey study among 100 EDOU patients ≥18 years-old evaluated for chest pain in the EDOU of a tertiary care center from September 1, 2020, to November 01, 2021. Five-point Likert-scale surveys were used to assess each Health Belief Model domain: Cues to Action, Perceived Susceptibility, Perceived Barriers, Perceived Self-Efficacy, and Perceived Benefits. Responses were categorized as agree or do not agree.
The participants were 49.0% (49/100) female, 39.0% (39/100) non-white, and had a mean age of 59.0 ± 12.4 years. Most (83.0% [83/100, 95% confidence interval (CI), 74.2%-89.8%]) agreed the EDOU is an appropriate place for HCL education and 52.0% (52/100, 95% CI, 41.8%-62.1%) were interested in talking with their EDOU care team about HCL. Regarding Perceived Susceptibility, 88.0% (88/100, 95% CI, 80.0%-93.6%) believed HCL to be bad for their health, while 41.0% (41/100, 95% CI, 31.3%-51.3%) believed medication costs could be a barrier. For Perceived Self-Efficacy, 76.0% (76/100, 95% CI, 66.4%-84.0%) were receptive to taking medications. Overall, 95.0% (95/100, 95% CI, 88.7%-98.4%) believed managing HCL would benefit their health.
This Health Belief Model-based survey indicates high patient interest in EDOU-initiated HCL care. Patients reported high rates of Perceived Susceptibility, Self-Efficacy, and Benefits and a minority found HCL therapy costs a barrier.
高胆固醇血症（HCL）在急诊科（ED）和 ED 观察单元（EDOU）的胸痛患者中很常见，但在这些情况下通常未得到解决。本研究的目的是使用健康信念模型评估 EDOU 中 HCL 护理的患者态度。
我们对 2020 年 9 月 1 日至 2021 年 11 月 1 日在一家三级护理中心的 EDOU 中接受胸痛评估的 100 名≥18 岁的 EDOU 患者进行了横断面调查研究。采用 5 分李克特量表评估每个健康信念模型领域：行动线索、感知易感性、感知障碍、感知自我效能和感知效益。反应分为同意或不同意。
参与者中 49.0%（49/100）为女性，39.0%（39/100）为非白人，平均年龄为 59.0±12.4 岁。大多数（83.0%[83/100，95%置信区间（CI），74.2%-89.8%]）同意 EDOU 是进行 HCL 教育的合适场所，52.0%（52/100，95%CI，41.8%-62.1%）有兴趣与他们的 EDOU 护理团队讨论 HCL。关于感知易感性，88.0%（88/100，95%CI，80.0%-93.6%）认为 HCL 对他们的健康有害，而 41.0%（41/100，95%CI，31.3%-51.3%）认为药物费用可能是一个障碍。关于感知自我效能，76.0%（76/100，95%CI，66.4%-84.0%）愿意服用药物。总体而言，95.0%（95/100，95%CI，88.7%-98.4%）认为管理 HCL 将有益于他们的健康。
基于健康信念模型的这项调查表明，患者对 EDOU 启动的 HCL 护理非常感兴趣。患者报告了高感知易感性、自我效能和效益的比率，少数人认为 HCL 治疗费用是一个障碍。
